Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.54), $0.05 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $2.49 million versus the consensus estimate of $854.29 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.